EUVIMEDEUVIMED entdecken
Multizentrische Studie

Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study

Juntaro Koyama iD, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Koji Kawai, Terukazu Nakamura, Takayuki Goto, Takahiro Osawa, Kazuo Nishimura, Norio Nonomura, Hiroyuki Nishiyama und 7 weitere

International Journal of Urology · 2025

DOI: 10.1111/iju.15622 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2025. Verfasst von Juntaro Koyama und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. Hauptthemen laut MEDLINE: Testicular Neoplasms, Cancer Survivors, Cardiovascular Diseases, Kidney Diseases. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate comorbidities in Japanese testicular cancer (TC) survivors in a multi‐institutional, cross‐sectional study.

Methods

This study enrolled TC survivors who visited any of the eight high‐volume institutions in Japan from 2018 to 2019. After obtaining informed consent, participants answered questionnaires about their comorbidities. We analyzed the impact of treatment on comorbidities rate in TC survivors.

Results

A total of 509 TC survivors responded to the comorbidity questionnaires. Median age at the time of response was 43 years (IQR 35–51 years) and median follow‐up period after treatment was 5.1 years (IQR 2.1–9.2 years). TC survivors were divided according to the number of cycles of chemotherapy into the following groups: None ( n = 153); 1–2 cycles ( n = 34); 3–4 cycles ( n = 234); or ≥5 cycles ( n = 88). The prevalence of kidney disease increased significantly with increasing number of cycles of chemotherapy ( p < 0.05). The relative risk of cardiovascular disease in the groups with three or more cycles was 2.6 compared to the group without chemotherapy.

Conclusion

The present study showed that the prevalence of kidney disease in TC survivors was increased with increasing number of cycles of chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsCancer SurvivorsCardiovascular DiseasesKidney DiseasesAntineoplastic Combined Chemotherapy ProtocolsHumansMaleCross-Sectional StudiesJapanAdultMiddle AgedComorbidityPrevalenceFollow-Up StudiesSurveys and QuestionnairesEast Asian People

Stichwörter der Autor:innen

cardiovascular diseasecomorbiditydiabeteskidney diseasetesticular cancer

Autor:innen und Institutionen

  • Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Department of Urology, Osaka International Cancer Institute, Osaka, Osaka, Japan.
  • Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
  • Department of Urology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
  • Department of Urology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.

ORCID-Profile: Juntaro Koyama

Zitieren

APA

Koyama, J., Yamashita, S., Kakimoto, K., Uemura, M., Kishida, T., Kawai, K., Nakamura, T., Goto, T., Osawa, T., Nishimura, K., Nonomura, N., Nishiyama, H., Shiraishi, T., Ukimura, O., Ogawa, O., Shinohara, N., Suzukamo, Y., Ito, A., & Arai, Y. (2025). Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study. International Journal of Urology. https://doi.org/10.1111/iju.15622

Vancouver

Koyama J, Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, et al. Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study. International Journal of Urology. 2025. doi:10.1111/iju.15622

BibTeX
@article{Koyama2025,
  author = {Koyama, Juntaro and Yamashita, Shinichi and Kakimoto, Kenichi and Uemura, Motohide and Kishida, Takeshi and Kawai, Koji and Nakamura, Terukazu and Goto, Takayuki and Osawa, Takahiro and Nishimura, Kazuo and Nonomura, Norio and Nishiyama, Hiroyuki and Shiraishi, Takumi and Ukimura, Osamu and Ogawa, Osamu and Shinohara, Nobuo and Suzukamo, Yoshimi and Ito, Akihiro and Arai, Yoichi},
  title = {Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.15622}
}
Kostenlos starten →